Development, characterizations and biocompatibility evaluations of intravitreal lipid implants.

about

Development, characterizations and biocompatibility evaluations of intravitreal lipid implants.

Item

http://www.wikidata.org/entity/Q40000461

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Development, characterizations ...... f intravitreal lipid implants.

@en

type

Item

label

Development, characterizations ...... f intravitreal lipid implants.

@en

prefLabel

Development, characterizations ...... f intravitreal lipid implants.

@en

P1476

Development, characterizations ...... of intravitreal lipid implants

@en

P2093

Abolfazl Mostafavi

http://www.w3.org/2001/XMLSchema#string

Fahimeh Asadi Amoli

http://www.w3.org/2001/XMLSchema#string

Farid Abedin Dorkoosh

http://www.w3.org/2001/XMLSchema#string

Lana Tamaddon

http://www.w3.org/2001/XMLSchema#string

Mohammad Riazi-Esfahani

http://www.w3.org/2001/XMLSchema#string

Morteza Rafiee-Tehrani

http://www.w3.org/2001/XMLSchema#string

Reza Karkhane

http://www.w3.org/2001/XMLSchema#string

Sara Aghazadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Biodegradable polymers for ocular drug delivery.

A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.

Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers.

Development and characterization of lipid microparticles as a drug carrier for somatostatin.

Peptide acylation by poly(alpha-hydroxy esters).

Monolithic triglyceride matrices: a controlled-release system for proteins.

In vitro investigation of lipid implants as a controlled release system for interleukin-18.

Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids.

Intravitreal clindamycin for toxoplasmic retinochoroiditis.

Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.

P304

e16414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.17795/JJNPP-16414

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24872944

http://www.w3.org/2001/XMLSchema#string

P932

4036376

http://www.w3.org/2001/XMLSchema#string